Translational Medical Research Commons^™

Addition Of An Anti-Staphylococcal Beta Lactam To Standard Antibiotic Therapy Does Not Decrease 90-Day Mortality Of Mrsa Bacteremia Versus Standard Therapy Alone, Monica Hessler

Clinical Research in Practice: The Journal of Team Hippocrates

A clinical decision report appraising Tong SYC, Lye DC, Yahav D, et al. Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial. JAMA. 2020;323(6):527–537. https://doi.org/10.1001/jama.2020.0103 for a patient with multiple comorbidities including heart failure, severe aortic regurgitation, aortic aneurysm and intellectual disability being treated for MRSA bacteremia who is intubated in the ICU.